The enormous opportunities offered by the market for the key players are the drug discovery, biomarker discovery, and diagnostics segments
Hyderabad, India -- (SBWIRE) -- 03/22/2018 -- According to a new market research report "Aptamers Market by type - (Peptide aptamers, Nucleic Acid aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), by Application - (Therapeutics Development, Diagnostics, Research and Development), by End users - (Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", published by MarketDataForecast™, the market is expected to reach USD 293 Million by 2021 from USD 128 Million in 2016, at a CAGR of 18.0%.
The key opportunities offered by the market for the key players are the medication disclosure, biomarker revelation, and diagnostics portions. The introduction of Macugen, the prime aptamer medicine and the initial mycotoxins test in grains has magnified the capability of aptamers in diagnostics and therapeutics.
Some of the key driving factors of this market are low cost and high efficiency of Aptamers, increased investment in R&D by several key players and the patient expiration of SELEX.
Ethical issues concerned with the Aptamers obtained from animals can be a major challenge the market has to face during the forecast period.
Browse Market Data Tables and Figures spread through 182 Pages and in-depth TOC on "Aptamers Market"
Early buyers will receive 10% customization on this report
DNA Based Aptamers are estimated to account for the largest market share in 2017
The Global Aptamers Market is broadly categorized based on type into Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers. DNA based Aptamers commanded the major market share while XNA based Aptamers are expected to grow at a high CAGR during the forecast period.
The Diagnostics Application segment is expected to dominate the market in 2016
By Application, the market is categorized into Therapeutics Development, Diagnostics, Research and
Development. Among these segments, Diagnostics segment has accounted for the major market share while Therapeutics segment is expected to have a major growth rate.
Hospitals are estimated to command for the largest share of the market during the forecast period
On the basis of end users, the market is segmented into Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres. Academic & Research Centres occupy a major market share while pharmaceutical companies segment is expected to witness a rapid growth during the forecast period.
Request a sample:
North America is estimated to command the largest share of the market
With respect to region, the market is divided into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America accounted for the largest share of the Antacids market in 2016.North America was closely followed by Europe. The Asia-Pacific market is expected to show a rapid growth with a high CAGR in the forecast period.
Some of the significant manufacturers of this market include AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter's Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
Browse Related Reports
Protein Expression Market:
Name: Mr. Abhishek Shukla
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.